Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:1542-1548

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, R. S.
Right arrow Articles by Johnson, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, R. S.
Right arrow Articles by Johnson, R. G., Jr

(Circulation. 1996;93:1542-1548.)
© 1996 American Heart Association, Inc.


Articles

Neointimal Thickening After Severe Coronary Artery Injury Is Limited by Short-term Administration of a Factor Xa Inhibitor

Results in a Porcine Model

Robert S. Schwartz, MD; Daniel J. Holder, PhD; David R. Holmes, Jr, MD; John P. Veinot, MD; Allan R. Camrud; Michael A. Jorgenson; Robert G. Johnson, Jr, MD, PhD

From the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn, and Departments of Pharmacology and Biometrics Research, Merck Research Laboratories, West Point, Pa.

Background Fibrin- and platelet-rich thrombus formations occur as the initial event after percutaneous transluminal coronary angioplasty. We therefore tested the hypothesis that short-term administration of the recombinant tick anticoagulant peptide (rTAP), a factor Xa inhibitor, would reduce the thickness of neointima at 28 days after injury in a porcine coronary balloon angioplasty model.

Methods and Results Continuous intravenous infusion of rTAP (average dose, 194 µg·kg-1·min-1) or placebo (vehicle only) was given to the study pigs for 60 hours. The goal of anticoagulation was to maintain the activated clotting time at 200 seconds. A central venous catheter was inserted 2 days before the procedure. On the day of coronary injury, the animals were administered boluses of rTAP (6.5 mg) and then underwent injury with an oversized metallic coil by standard methods in the right, circumflex, or left anterior descending coronary artery. No significant difference in vascular injury between rTAP and vehicle control was observed after euthanasia at 28 days. Significantly less neointimal thickening occurred in the rTAP-treated animals (thickness, mean±SD: 0.30±0.08 mm) compared with the control (0.48±0.12 mm, P<.001).

Conclusions The specific factor Xa inhibitor rTAP, when given in fully anticoagulant doses for a short duration after coronary artery injury in the porcine model, resulted in a long-term decrease in neointimal thickness. These results implicate thrombin generation in neointimal formation and suggest that administration of a potent antithrombotic for several days immediately after the procedure may influence the long-term outcome of the coronary injury with a decrease in neointimal formation.


Key Words: restenosis • angioplasty • peptides




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
Y. Suzuki, A. C. Yeung, and F. Ikeno
The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 373 - 383.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D.L. Tharp, B.R. Wamhoff, H. Wulff, G. Raman, A. Cheong, and D.K. Bowles
Local Delivery of the KCa3.1 Blocker, TRAM-34, Prevents Acute Angioplasty-Induced Coronary Smooth Muscle Phenotypic Modulation and Limits Stenosis
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1084 - 1089.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
A. G. Touchard and R. S. Schwartz
Preclinical Restenosis Models: Challenges and Successes
Toxicol Pathol, January 1, 2006; 34(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Matsumoto, T. Uwatoku, K. Oi, K. Abe, T. Hattori, K. Morishige, Y. Eto, Y. Fukumoto, K.-i. Nakamura, Y. Shibata, et al.
Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms
Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
N. F. Meneveau, B. D. Klugherz, B. Chaquor, M. A. Golden, M. M. Jouille, E. Macarek, P. B. Weisz, and R. L. Wilensky
Separate and Combined Effects of Local and Continuous Intravenous Administration of {beta}-Cyclodextrin Tetradecasulfate on Intimal Hyperplasia after Angioplasty in Porcine Coronary Arteries
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1): 53 - 60.
[Abstract] [PDF]


Home page
CirculationHome page
M. N. Babapulle and M. J. Eisenberg
Coated Stents for the Prevention of Restenosis: Part I
Circulation, November 19, 2002; 106(21): 2734 - 2740.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. I. Lev, J. D. Marmur, M. Zdravkovic, J. I. Osende, J. Robbins, J. A. Delfin, M. Richard, E. Erhardtsen, M. S. Thomsen, A. M. Lincoff, et al.
Antithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIa: An Ex Vivo Human Study
Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 1036 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
O. P. Blanc-Brude, R. C. Chambers, P. Leoni, W. A. Dik, and G. J. Laurent
Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF
Am J Physiol Cell Physiol, August 1, 2001; 281(2): C681 - C689.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Roque, E. D. Reis, V. Fuster, A. Padurean, J. T. Fallon, M. B. Taubman, J. H. Chesebro, and J. J. Badimon
Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2303 - 2310.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Cottin, M. Kollum, R. Chan, B. Bhargava, Y. Vodovotz, and R. Waksman
Vascular repair after balloon overstretch injury in porcine model effects of intracoronary radiation
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1389 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. St. Pierre, L.-Y. Yang, K. Tamirisa, D. Scherrer, P. De Ciechi, P. Eisenberg, E. Tolunay, and D. Abendschein
Tissue Factor Pathway Inhibitor Attenuates Procoagulant Activity and Upregulation of Tissue Factor at the Site of Balloon-Induced Arterial Injury in Pigs
Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2263 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. J. Kullo, R. D. Simari, and R. S. Schwartz
Vascular Gene Transfer : From Bench to Bedside
Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 196 - 207.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Ueda, M. Kitakaze, M. Imakita, H. Ishibashi-Ueda, T. Minamino, H. Asanuma, T. Ozaki, E. Imamura, T. Kuzuya, and M. Hori
Glycoprotein IIb/IIIa Antagonist FK633 Could Not Prevent Neointimal Thickening in Stent Implantation Model of Canine Coronary Artery
Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Gallo, A. Padurean, V. Toschi, J. Bichler, J. T. Fallon, J. H. Chesebro, V. Fuster, and J. J. Badimon
Prolonged Thrombin Inhibition Reduces Restenosis After Balloon Angioplasty in Porcine Coronary Arteries
Circulation, February 17, 1998; 97(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Ghigliotti, A. R. Waissbluth, C. Speidel, D. R. Abendschein, and P. R. Eisenberg
Prolonged Activation of Prothrombin on the Vascular Wall After Arterial Injury
Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 250 - 257.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Oltrona, C. M. Speidel, D. Recchia, S. A. Wickline, P. R. Eisenberg, and D. R. Abendschein
Inhibition of Tissue Factor–Mediated Coagulation Markedly Attenuates Stenosis After Balloon-Induced Arterial Injury in Minipigs
Circulation, July 15, 1997; 96(2): 646 - 652.
[Abstract] [Full Text]